iifl-logo

Marksans Pharma Ltd Historical Data

253.35
(0.56%)
Jun 9, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Marksans Pharma Ltd Historical Data

10/05/2025calendar-icon
10/06/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

12-May-2025

228.5

231.69222222.7126,38435,49,31,932.336,67,998

13-May-2025

224.49

239223.5237.439,22665,48,10,275.0210,83,648

14-May-2025

237.57

242.73234238.2721,99545,03,80,137.1810,61,403

15-May-2025

237

243.65236.28239.6123,82527,19,46,115.94,19,986

16-May-2025

240.25

243.47238.5241.414,23419,01,49,343.592,91,418

19-May-2025

243

256.08238.3253.5138,93161,94,35,911.667,10,723

20-May-2025

241

249.86235.12236.7835,19554,26,65,265.749,31,529

21-May-2025

238.51

252231.41250.2143,33464,24,00,239.839,74,289

22-May-2025

249.4

249.6242.99246.817,14420,84,09,671.513,28,203

23-May-2025

246.85

248.5243.7246.6710,49213,78,93,948.241,79,942

26-May-2025

246.5

253.5244.25251.8320,89730,53,26,273.443,82,368

27-May-2025

253.7

254.18246.85251.9913,59419,07,10,215.862,59,993

28-May-2025

253.9

254.17248.16250.2711,02017,31,57,480.722,70,580

29-May-2025

251.85

261.83250.52260.2431,28147,85,73,062.646,93,621

30-May-2025

261.4

265258.66261.4226,73032,16,17,620.133,88,380

02-Jun-2025

260

260254.55255.1516,71418,00,35,918.753,38,153

03-Jun-2025

255.6

262.5254.1261.3521,96431,59,05,800.855,34,328

04-Jun-2025

262

263255.9256.815,42319,37,27,0912,58,362

05-Jun-2025

256.95

261.05256.5257.8513,56716,44,03,380.72,01,241

06-Jun-2025

257.85

261.35251.05251.9523,73029,46,80,701.755,18,468

09-Jun-2025

254.55

257.7252.5253.356,12510,59,54,149.752,12,015

Marksans Pharma: Related NEWS

Marksans Pharma’s Relonchem Gets UK MHRA Approval for Baclofen 10 mg
21 Mar 2025|12:02 PM

Relonchem Ltd has secured Marketing Authorisation from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for Baclofen 10 mg Tablets

Read More
Marksans Pharma gets USFDA approval for anti-allergy drug
22 Nov 2024|02:54 PM

The US Food and Drug Administration (FDA) approved the pharmaceutical company's Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.